Pharmacy Shared Resource
The Pharmacy Shared Resource within the Mayo Clinic Cancer Center provides comprehensive pharmacy services for cancer-related clinical trials at Mayo Clinic's campuses in Arizona, Florida and Minnesota.
The services of the Pharmacy Shared Resource are essential for protocol development, protocol initiation and patient treatment in cancer clinical trials throughout the Mayo Clinic Cancer Center. The Pharmacy Shared Resource supports about 400 active cancer clinical trials.
For Mayo Clinic Cancer Center members, the Pharmacy Shared Resource:
- Procures, stores and is accountable for commercial and investigational chemotherapy agents
- Provides safe handling and sterile admixture of cytotoxic agents, growth factors, immunomodulatory agents, antiemetics and supportive care medications for intravenous, intramuscular, subcutaneous and intrathecal administration
- Labels and dispenses medications for administration in treatment suites, in the Clinical Research and Trials Unit and in the homes of patients
- Provides ambulatory intravenous pumps and medications for home infusion therapy
- Assists with protocol development and review, particularly budget, treatment, drug and adverse reaction sections
- Supports and oversees the web-based investigational software and clinical document management computerized physician order entry system
- Manages chemotherapy-related inquiries to the Mayo Clinic Drug Information Service from physicians and allied health professionals in medical oncology and hematology
- Provides electronic or in-person medication therapy management services to patients taking investigational medications deemed high risk for drug-drug interactions
With special expertise in both investigational and commercially available cancer therapeutic agents, the Pharmacy Shared Resource ensures a uniformly high standard of safe and accurate treatment for Mayo Clinic patients with cancer.
Policies and procedures in the Pharmacy Shared Resource are consistent with guidelines set forth by the American Society of Health-System Pharmacists and with recommendations from The Joint Commission.